A Look at the Breast Cancer Landscape: An Expert's Take on the Newly Approved Daiichi Sankyo Drug, ENHERTU, SGEN's tucatinib, & the Role of IO therapyTicker(s): D4S.F, SGEN
Name: Dr Ruta Rao - MD
Institution: Rush University Medical Center
- Medical Director, Rush University Cancer Center & Associate Professor Department of Internal Medicine, Rush Medical College.
- Currently manages over 500 patients with breast cancer and has prescribed both ENHERTU and TUKYSA.
- Expert in the role IO therapy plays in treating breast cancer.
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.